Barclays raised the firm’s price target on Bath & Body Works to $35 from $31 and keeps an Equal Weight rating on the shares. The CEO change is focused on profitable growth and Bath & Body also announced a positive Q1 preannouncement, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works: Strong Earnings and Strategic Leadership Drive Buy Rating
- Bath & Body Works: Strategic Leadership and Strong Fundamentals Drive Buy Rating
- BofA remains bullish on Bath & Body Works following CEO appointment
- Moody’s cuts U.S. rating, Trump urges Walmart to ‘eat’ tariffs: Morning Buzz
- Bath & Body Works (BBWI) Names Former Nike Executive as Its New CEO